Cariporide

Drug Profile

Cariporide

Alternative Names: HOE 604; HOE 642

Latest Information Update: 27 May 2003

Price : $50

At a glance

  • Originator Aventis
  • Class Anti-ischaemics; Guanidines; Small molecules; Sulfones
  • Mechanism of Action Sodium hydrogen antiporter inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Arrhythmias; Ischaemic heart disorders; Myocardial infarction; Unstable angina pectoris

Most Recent Events

  • 16 May 2003 Discontinued - Phase-II for Arrhythmias in Germany (IV-injection)
  • 16 May 2003 Discontinued - Phase-II for Myocardial infarction in Japan (unspecified route)
  • 16 May 2003 Discontinued - Phase-II for Myocardial infarction in Europe (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top